email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2641-1725

LOJ Medical Sciences

Opinion(ISSN: 2641-1725)

Cannabidiol and Amyotrophic Lateral Sclerosis: A Disease-Modifying Treatment

Volume 3 - Issue 5

Marco Orsini1*, Acary Souza Bulle Oliveira2, Adriana Leico Oda2, Carlos Henrique Melo Reis1, Victor Hugo Bastos3, Bruna Velasques4 and Marcos RG de Freitas1

  • Author Information Open or Close
    • 1Medicine Department, Iguacu University, Brazil
    • 2Neurology Department, Sao Paulo Federal University, Brazil
    • 3Fellow Programa em Mapeamento Cerebral e Funcionalidade, Federal University Piaui, Brazil
    • 4Rio de Janeiro Federal University, Brazil

    *Corresponding author: Marco Orsini, Department of Neurology, Fluminense Federal University, Brazil

Received: October 13, 2019;   Published: October 16, 2019

DOI: 10.32474/LOJMS.2019.03.000174

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Amyotrophic Lateral Sclerosis can be defined as a progressive, degenerative and inexorable disease that leads to the depletion of upper and lower motor neurons. With the evolution of the disease, the patients present several damages regarding their daily activities. Muscle weakness is undoubtedly the leading cause of functional disability, swallowing, speech and breathing problems [1,2].

Introduction| References|

https://www.high-endrolex.com/21